Patients with major depressive disorder,Clinical study of sleep EEG measurement using DCT (Decentralized Clinical Trial) - Patients with major depressive disorder,Clinical study of sleep EEG measurement using DCT (Decentralized Clinical Trial)

Medical Corporation Chiseikai Tokyo Center Clinic0 sites60 target enrollmentSeptember 1, 2023

Conditionsmajor depressive disorder

Overview

Phase: 未知
Intervention: Not specified
Conditions: major depressive disorder
Sponsor: Medical Corporation Chiseikai Tokyo Center Clinic
Enrollment: 60
Status: Recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

September 1, 2023

End Date

March 31, 2024

Last Updated

2 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Medical Corporation Chiseikai Tokyo Center Clinic

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•Patients with major depressive disorder: 1\)Persons with schizophrenia and other comorbid psychotic disorders according to DSM\-5 diagnostic criteria. Also, those receiving treatment for diseases of the respiratory system, circulatory system, digestive system, immune system, liver, kidney, haematopoietic function or endocrine function. 2\)Persons with any of the following comorbidities based on DSM\-5 diagnostic criteria: delirium, dementia, substance\-related disorder, borderline personality disorder, eating disorder, obsessive\-compulsive disorder, panic disorder, post\-traumatic stress disorder, intellectual capacity disorder, autistic spectrum disorder. 3\)Persons at significant risk of suicide who have had suicidal thoughts within the past 3months or suicidal behaviour within 1year prior to the start of the screening period, corresponding to items 4 or 5 of the Columbia Suicide Rating Scale (C\-SSRS). 4\)Patients who are hospitalised or scheduled to be hospitalised for treatment during the study period. 5\)Persons who take benzodiazepines,lithium carbonate or antihistamine drugs during the study period from 2days before POINT2 to the end of POINT2 and from 2days before POINT3 to the end of POINT4\. 6\)Persons with alcohol abuse or illicit drug abuse or a history of such abuse. 7\)Persons who are judged by the researcher or others to be unsuitable for the study. Healthy adults: 1\)Persons receiving treatment for diseases of the respiratory, circulatory, mental, nervous, digestive, immune, liver, kidney, haematopoietic or endocrine systems. 2\)Persons for whom the Brief Structured Interview for Mental Illness (M.I.N.I.) screen version questionnaire suggests suspicion of a mental disorder or who have a history of such a disorder. 3\)Persons who answered 'yes' to question 1 or 2 on suicidal ideation in the Columbia Suicide Rating Scale (C\-SSRS), or who answered 'yes' to any of the questions on suicidal behaviour. 4\)Same as 6\) 7\) above.